A Successful Conclusion | Grandglow Shines at PHARMED & HEALTHCARE VIETNAM 2026, Gaining Full Harvest at the Prestigious Southeast Asian Medical Exhibition.

The three-day PHARMED & HEALTHCARE VIETNAM 2026 has successfully concluded at Saigon Exhibition and Convention Center (SECC) in Ho Chi Minh City. As Vietnam’s largest B2B professional medical exhibition and one of Southeast Asia’s most influential medical events, this year’s show brought together medical brands from more than 20 countries and regions worldwide. Tens of thousands of medical institution purchasers, distributors and industry experts attended the event. It serves as a core barometer for the ASEAN healthcare market and a vital trading platform for Chinese medical device manufacturers expanding into Southeast Asia.

Supported by the Ministry of Health of Viet Nam, the exhibition covers the full industrial chain of medical devices, pharmaceuticals, rehabilitation and elderly care. The medical device segment attracted the highest audience attention, accounting for 25.5% of total visitor interest. Complemented by B2B business matchmaking sessions and international healthcare industry forums, the event integrates product demonstration, technical exchange and business negotiation into one seamless ecosystem. Access to high-quality professional buyers constitutes the core reason why Grandglow chose to participate in the exhibition.

At Booth V13, Grandglow showcased its flagship products including the PRF-300 plasma and high-frequency surgical system, radiofrequency thermocoagulator, disposable bipolar high-frequency surgical electrodes, and disposable monopolar surgical electrodes. On-site equipment demonstrations and clinical solution exchanges were held, welcoming numerous business visitors from ASEAN countries such as Vietnam, Cambodia, Laos and Malaysia.

The participation yielded fruitful and rewarding results. On one hand, Grandglow connected with high-potential prospective partners, laying a solid foundation for customer acquisition and business expansion in overseas markets. On the other hand, by engaging directly with the end-user healthcare market of ASEAN, the company accurately identified local clinical requirements and industry access standards, accumulating first-hand market data to strongly support product localization adaptation and refined market operation. Meanwhile, leveraging this premier exhibition platform, Grandglow has significantly boosted brand awareness and credibility within Southeast Asia’s medical sector, building a distinguished brand representative for Chinese minimally invasive medical devices going global.

The exhibition has concluded, yet our in-depth market pursuit continues. Moving forward, Grandglow will efficiently advance partnership negotiations and implementation follow-ups to accelerate the improvement of its Southeast Asian market layout. Going forward, we will keep deepening our presence in the ASEAN healthcare sector. Leveraging our strengths in independently developed technologies, we will continuously optimize product solutions and overseas service systems. We empower the upgrading of medical institutions across Southeast Asia with high-quality domestic minimally invasive medical devices. By further exploring overseas markets and enabling global healthcare, we will open a brand-new chapter for our global expansion.